Deaths Due to Alcohol Use; Steps for the Sedentary Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
Cardiometabolic Disorders Tend to Accompany a 'Lazy Eye' Persistent amblyopia associated with myocardial infarction and death Mar 08, 2024
One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia? Even following this rule, increased residual gastric content still prevalent Mar 07, 2024
FDA Clears First OTC Continuous Glucose Monitor Dexcom's Stelo system available without a prescription by the summer Mar 06, 2024
Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D News and commentary from the endocrinology world Mar 05, 2024
FDA Says Eating Yogurt May Reduce Diabetes Risk Products will be allowed to carry claims as long as they don't mislead consumers Mar 04, 2024
Bariatric Surgery a Long-Term Winner for Type 2 Diabetes Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
FDA: Don't Use Smartwatches, Smart Rings for Blood Glucose Measurements Noninvasive devices that don't pierce the skin can give inaccurate measurements Feb 22, 2024
T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals News and commentary from the endocrinology world Feb 20, 2024
States Target Health Insurers' Red Tape Around Prior Authorization Pending bills in multiple states include policies backed by the AMA Feb 19, 2024
SGLT2 Inhibitors Tied to Better NAFLD Outcomes vs Other Antidiabetic Agents Class of drug associated with highest odds of NAFLD regression for patients with type 2 diabetes Feb 14, 2024
Denosumab Protective Against Diabetes? Study found lower diabetes incidence with osteoporosis drug for patients who stayed on treatment Feb 13, 2024
Rapid Weight Loss a Diabetic Retinopathy Risk? While research is conflicting, GLP-1 therapies might cause transient worsening of retinal disease Feb 12, 2024
Can a Common Diabetes Drug Turn Patients' Urine Into Alcohol? Case study highlights importance of proper urine sample storage Feb 07, 2024
More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk News and commentary from the endocrinology world Feb 06, 2024
Durable Weight Loss Follows Just a Few Injections of Novel Drug Most of the body weight reduction persisted 150 days after the last dose in an early-phase trial Feb 05, 2024
Health Effects of Diabetes Remission; High-Deductible Plans for Cancer Patients Also in TTHealthWatch: USPSTF weighs in on screening for language disorders or delays in kids Feb 03, 2024 podcast
Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply News and commentary from the endocrinology world Jan 30, 2024
Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care Study looked at how three recommendations changed primary care decisions Jan 29, 2024
One Class of Antidiabetic Linked With Lower Kidney Stone Risk Study compared SGLT2 inhibitors with GLP-1 agonists and DPP-4 inhibitors Jan 29, 2024
Can the Eye Reveal Cardiac and Lung Disease -- Plus Much More? Researchers link thinner retinal layers to higher risk of multiple diseases Jan 26, 2024
Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism Daily treatment substantially reduced hypoglycemia over 13 weeks Jan 24, 2024
T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans? News and commentary from the endocrinology world Jan 23, 2024
Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain News and commentary from the endocrinology world Jan 16, 2024
FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Now Preliminary evaluation reassures, while the agency's review continues Jan 11, 2024
T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Win News and commentary from the endocrinology world Jan 09, 2024
No Increased Risk of Suicidal Ideation With GLP-1 Drugs Semaglutide shows lower risk of suicidal ideation than other obesity, diabetes drugs Jan 08, 2024
Maternal Type 1 Diabetes an Outsized Red Flag for Child Heart Defect Risk But don't ignore maternal overweight, obesity, and gestational diabetes, study says Jan 05, 2024
Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists Researchers looked at 7-year patient data Jan 04, 2024
In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective Risk of all-cause mortality, MAKE, and MACE were significantly reduced Jan 04, 2024
Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes News and commentary from the endocrinology world Jan 02, 2024
Bernie Sanders Has COVID; Global Fake Ozempic Problem; Nitazenes, the New Fentanyl? Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Dec 29, 2023
Food as Diabetes Medicine? Maybe Not, Trial Suggests But intensive program did help boost engagement with healthcare Dec 26, 2023
Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth News and commentary from the endocrinology world Dec 26, 2023
Deep Flaws in FDA's Device Oversight, and Patient Harm, Exposed in Lawsuits, Records "What is the threshold for the FDA to step in and do something?" Dec 24, 2023
Can a GLP-1 Agonist Improve Parkinson's Symptoms? A version of exenatide failed a phase II trial, but hinted at benefits in patients under 60 Dec 19, 2023
Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry News and commentary from the endocrinology world Dec 19, 2023
Cannabis Exposure During Pregnancy; Tirzepatide Cessation and Weight Gain Also in TTHealthWatch: newer vaccine technologies in adults Dec 16, 2023 podcast
Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadavers Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Dec 14, 2023